TRI-MIX Injectable Compounded Drug Recalled for Sterility Assurance Failure
Talon Compounding Pharmacy is recalling TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 25 injectable medication due to lack of assurance of sterility. The product was distributed across the United States, Washington, D.C., and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterility defect in an injectable pharmaceutical product. Sterility assurance failures in injectable drugs present direct risk of serious infection and other severe harm upon administration, meeting the Class II with significant-injury-risk criterion.
Plain-English summary
Talon Compounding Pharmacy, located in San Antonio, Texas, is recalling TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 25 INJECTABLE due to lack of assurance of sterility. The product is a prescription-only injectable medication.
The recall affects lot 07232021:18 with a beyond-use date (BUD) of 11/30/2021. The product was distributed throughout the United States, including Washington, D.C. and Puerto Rico.
Injectable medications that lack assured sterility present a risk of infection and other serious complications when administered to patients. Consumers or healthcare providers who have this product should discontinue use and consult with their healthcare provider or pharmacist regarding alternative treatment options.
The recalled product
- Product
- TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 25 INJ**T 106** INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-failure
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 07232021:18 BUD: 11/30/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27